Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide, and mortality rates continue to rise annually [1]. The liver stands out as the primary site for CRC metastases [2], with approximately 50% of patients developing liver metastases [3]. CRLM represents a significant cause of mortality...
Gastric cancer is the fifth most commonly diagnosed cancer and the fifth leading cause of cancer-related mortality worldwide [1]. The majority of patients are diagnosed with locally advanced gastric cancer (LAGC), and the neoadjuvant chemotherapy (NAC) combined with radical surgery has brought survival...
Neoadjuvant therapy is considered the standard-of-care treatment of stage I-III, locally advanced triple-negative breast cancer (TNBC). Neoadjuvant therapy increases the success rate for breast conservation surgery by reducing tumor burden and provides the opportunity to treat micro-metastases in a naïve...
Gastric cancer (GC) occupies a prominent position globally, ranking as the fifth most prevalent malignancy and the third leading cause of cancer-related deaths, posing a significant health burden worldwide [1].Within gastric cancer management protocols, preoperative T-staging constitutes a fundamental...